Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Catalyst Pharmaceutical Inc. (CPRX)

NASDAQ

$--

(--)

Market Closed

Catalyst Pharmaceutical Inc. (CPRX) Live Price Chart

Last updated: ⁦2026-09-07 16:56:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Catalyst Pharmaceutical Inc. (CPRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Catalyst Pharmaceutical Inc. (CPRX) Latest Closing Stock Price

Catalyst Pharmaceutical Inc. (CPRX) last closed at $-- as of --, -- from the previous close of $--.

During the latest regular trading session, CPRX traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.

Catalyst Pharmaceutical Inc. (CPRX) 7-Day Stock Price Change

Over the past seven days, Catalyst Pharmaceutical Inc. (CPRX) moved from $31.45 to $31.49, representing a gain of 0.13% ($0.04).

The stock traded between $31.45 and $31.51 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.

The average daily volume was 3.95 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Catalyst Pharmaceutical Inc. (CPRX)?

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Catalyst Pharmaceutical Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	182
Exchange	NASDAQ
Company Website	https://www.catalystpharma.com

How to Buy Catalyst Pharmaceutical Inc. (CPRX) Stock on MEXC

Eligible investors can buy real shares of Catalyst Pharmaceutical Inc. (CPRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CPRX and Place Your Order

Open the RealStocks trading page and search for CPRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Catalyst Pharmaceutical Inc. (CPRX) share price today?

Catalyst Pharmaceutical Inc. (CPRX) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is CPRX stock going up or down today?

As of --, CPRX is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is CPRX pre-market price?

As of --, CPRX is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CPRX after-hours price?

As of --, CPRX is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is CPRX stock trading now?

CPRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CPRX sit relative to its 52-week high and low?

Over the past 52 weeks, CPRX has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Catalyst Pharmaceutical Inc. in?

Catalyst Pharmaceutical Inc. (CPRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Catalyst Pharmaceutical Inc.'s market capitalisation and where is it listed?

Catalyst Pharmaceutical Inc. is listed on the NASDAQ exchange with a market capitalisation of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CPRX valued in terms of P/E ratio and EPS?

CPRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Catalyst Pharmaceutical Inc. pay a dividend?

Catalyst Pharmaceutical Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.